Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Neuropeptides
|
April 1, 1985
A monoclonal antibody specific for a dynorphin precursor
R W Barrett, A Goldstein
European Journal of Pharmacology
|
March 29, 1989
Biochemical evidence for somatostatin receptors in murine neuroblastoma clone N1E-115
M McKinney, R W Barrett
Molecular Pharmacology
|
June 1, 1987
Ligand dissociation constants from competition binding assays: errors associated with ligand depletion
A Goldstein, R W Barrett
Life Sciences
|
December 12, 1983
Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes
R W Barrett, J L Vaught
European Journal of Pharmacology
|
June 4, 1982
The effects of receptor selective opioid peptides on morphine-induced analgesia
R W Barrett, J L Vaught
Neurochemical Research
|
December 1, 1983
Comparison of the filtration and centrifugation methods for assaying [3H](D-ala2, D-leu5)enkephalin binding to mouse brain membranes
R W Barrett, J L Vaught
Biochemical and Biophysical Research Communications
|
May 29, 1986
Comparative immuno-removal: a novel method for estimating the concentration of an unknown immunoreactive compound
R W Barrett, I F James, A Goldstein
Molecular Pharmacology
|
August 1, 1989
Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays
R W Barrett, M E Steffey, C A Wolfram
Molecular Pharmacology
|
April 1, 1989
Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis
R W Barrett, M E Steffey, C A Wolfram
FEBS Letters
|
February 11, 1991
A chimeric D2 dopamine/m1 muscarinic receptor with D2 binding specificity mobilizes intracellular calcium in response to dopamine
B P England, M S Ackerman, R W Barrett
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Neuropeptides
|
April 1, 1985
A monoclonal antibody specific for a dynorphin precursor
R W Barrett, A Goldstein
European Journal of Pharmacology
|
March 29, 1989
Biochemical evidence for somatostatin receptors in murine neuroblastoma clone N1E-115
M McKinney, R W Barrett
Molecular Pharmacology
|
June 1, 1987
Ligand dissociation constants from competition binding assays: errors associated with ligand depletion
A Goldstein, R W Barrett
Life Sciences
|
December 12, 1983
Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes
R W Barrett, J L Vaught
European Journal of Pharmacology
|
June 4, 1982
The effects of receptor selective opioid peptides on morphine-induced analgesia
R W Barrett, J L Vaught
Neurochemical Research
|
December 1, 1983
Comparison of the filtration and centrifugation methods for assaying [3H](D-ala2, D-leu5)enkephalin binding to mouse brain membranes
R W Barrett, J L Vaught
Biochemical and Biophysical Research Communications
|
May 29, 1986
Comparative immuno-removal: a novel method for estimating the concentration of an unknown immunoreactive compound
R W Barrett, I F James, A Goldstein
Molecular Pharmacology
|
August 1, 1989
Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays
R W Barrett, M E Steffey, C A Wolfram
Molecular Pharmacology
|
April 1, 1989
Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis
R W Barrett, M E Steffey, C A Wolfram
FEBS Letters
|
February 11, 1991
A chimeric D2 dopamine/m1 muscarinic receptor with D2 binding specificity mobilizes intracellular calcium in response to dopamine
B P England, M S Ackerman, R W Barrett
Page
of 5